An experimental injectable drug appears more versatile than existing medications in treating people with different forms of severe, hard-to-control asthma, clinical trial results show.
There are many different types of asthma brought on by many different triggers, and a number of monoclonal antibody medications -- called "biologics" -- have been crafted to target distinct asthma triggers....
Heart complications are rare among college athletes who have had COVID-19, according to a small study.
"Our findings may offer reassurance to high school athletes, coaches and parents where resources for testing can be limited," said senior author Dr. Ranjit Philip, assistant professor in pediatric cardiology at the University of Tennessee Health Science Center, in Memphis.
While COVID-19 research efforts must now shift toward the development of a pill that can prevent serious illness in the recently infected, experts say.
"We need a pill that can keep people out of the hospital, and the time to develop that is right now," Dr. Rajesh Gandhi said during a Thursday media briefing by the Infectious Diseases Society of America. He is director of HIV Clinical Ser...
In rare cases, people hospitalized for COVID-19 can develop heart failure, even if their hearts were previously healthy, new research shows.
The researchers found that of over 6,400 COVID-19 patients at their hospital, 0.6% newly developed heart failure. That included eight patients -- mostly relatively young men -- with no history of heart disease or risk factors for it.
As if the headaches and stuffy nose aren't bad enough, chronic sinus trouble often leaves patients foggy-headed and depressed. Now, new research suggests one possible reason why: Sinusitis may trigger changes in brain activity.
"Chronic sinusitis is incredibly common," said study lead author Dr. Aria Jafari. Upwards of 11% of all Americans are affected, added Jafari, an assistant profess...
Dermatologists liken skin to a window that can reveal what is going on inside the body, and a rash that sometimes follows a COVID-19 vaccine is one example.
When you get the shot, your immune system activates, preparing to recognize and fight off the virus in the future. This response and the inflammation that goes with it can occasionally result in a rash. But experts say as long as it h...
In very rare cases, children infected with the new coronavirus can develop a severe illness known as multisystem inflammatory syndrome (MIS-C). Now, research finds that these young patients often develop neurologic symptoms along with the respiratory issues they might face.
These neurologic symptoms were present in half of children who were hospitalized with MIS-C, U.K. researchers say.
Robert Preidt and Ernie Mundell HealthDay Reporters
Once you've landed that coveted coronavirus vaccine appointment, you'll likely have to fill out a form on your medical history and whether you're allergic to any of the vaccine's ingredients. But there could be another question waiting for you: Have you ever had dermal filler injections?
That's because -- in rare cases -- people who've had the face-plumping injections can develop a mild, ...
In a discovery that shows carpal tunnel syndrome doesn't strike just office workers, researchers report that people who work in construction or manufacturing have a higher risk of carpal tunnel syndrome than those with desk jobs.
Why the higher rates of injury among manual laborers? Investigators found such work requires lifting, gripping and forceful wrist motion, all of which are associ...
In January, the coronavirus swept through Brian and Maria Padla's family of seven in Philadelphia, starting with their oldest daughter, 16, and then infecting Brian, Maria, and their four younger children.
The virus seemingly came and went without much fanfare for the family. During their two-week-long quarantine, the kids spent a day or two with runny noses and low-grade fevers. Brian an...
Yet another organ seems to be affected by a bout of COVID-19: the thyroid.
Italian researchers have examined the thyroids of dozens of patients who've recovered from moderate-to-severe cases of COVID-19. The study found evidence that SARS-CoV-2 infection may trigger an inflammation of the gland in some patients.
Whether that inflammation can cause long-term dysfunction is still unc...
Ernie Mundell and Robert Preidt HealthDay Reporters
Two new studies suggest that the jury is still out on whether the arthritis drug tocilizumab helps those with severe COVID-19.
Both reports were published recently in the New England Journal of Medicine. The first, from scientists at the University of California, San Diego, found tocilizumab didn't improve outcomes or reduce the risk of death in patients with severe COVID-19 pneu...
Full doses of blood thinners can benefit patients hospitalized with COVID-19, but the severity of their illness matters, researchers say.
The new global analysis found that hospitalized patients with moderate COVID-19 may benefit from the drugs' clot-preventing powers, but patients with illness so severe it requires admission to an intensive care unit may not.
Here's one reason why past or current smoking may handicap you if you are battling breast cancer: New research suggests that nicotine promotes the spread of the disease to your lungs.
Smoking is known to increase the risk that breast cancer will spread, which lowers the survival rate by one-third at diagnosis. But the role of nicotine in the spread of breast cancer to the lungs has been l...
New research offers a novel explanation for the long-term brain problems many COVID-19 patients experience.
Many coronavirus patients report headaches and "brain fog" for weeks or months after they recover from respiratory symptoms. It's been believed that these lingering neurological issues are the result of nerve cell damage, but the new study suggests that the virus may instead be stri...
Blood vessel damage and inflammation in the brains of deceased COVID-19 patients suggest the damage is not caused by the virus, but the body's immune response to it.
Researchers from the U.S. National Institutes of Health (NIH) consistently found signs of damage caused by thinning and leaky brain blood vessels in tissue samples from patients who died shortly after getting COVID-19.
Respiratory problems and other factors -- not inflammation -- may explain why obese people are more likely to have severe COVID-19 and die from it, according to a new study.
Other studies have shown that overweight and obese COVID-19 patients are more likely to be admitted to intensive care, to require mechanical ventilation, and to die. Population-level studies also indicate that countri...
Compounds in meat may trigger wheezing in some children that can potentially lead to asthma or other respiratory conditions, a new study suggests.
These compounds, called advanced glycation end products (AGEs), are released as meat is cooked at high temperatures while grilling, frying or roasting. AGEs attach themselves to cells in the lungs, causing inflammation and an immune system resp...
While loss of smell is a symptom of COVID-19, don't panic -- there are a variety of other possible causes, one expert says.
"It can be due to nasal or sinus inflammation, or other viral infections distinct from COVID-19," explained Dr. Bobby Tajudeen, director of rhinology, sinus surgery and skull base surgery at Rush University Medical Center in Chicago.
Rheumatoid arthritis patients who are in remission have significantly higher body temperatures than people without the joint disease, new research shows.
The study included 32 rheumatoid arthritis patients who were in remission and a healthy "control" group of 51 people without rheumatoid arthritis, who all had thermal scans of different areas of their feet.
Older adults exposed to air pollution might have a heightened risk of abnormal "plaque" accumulation in the brain, a new study suggests.
Plaques refer to clumps of protein called beta-amyloid that build up in the brains of people with Alzheimer's disease. In the new study, researchers found that among older adults with memory and thinking problems, those exposed to higher levels of air po...
The spice that adds punch to your favorite Kung Pao chicken, Tex-Mex chili or Indian curry may also help save your life.
Preliminary research shows that eating chili pepper may reduce your risk of death from heart disease, cancer and other causes, building on past studies that have found chili pepper to have health benefits.
"I think a lot of people are going to find this informatio...
When the new coronavirus pandemic first began, respiratory distress immediately became the hallmark of severe COVID-19 illness. News reports focused on the inability to breathe, low oxygen saturation levels and the alarming need for ventilators.
But six months later, experts are becoming increasingly concerned about a very different COVID-19 phenomenon, one that spares the lungs only ...
Biologic therapy for the skin condition psoriasis may reduce patients' risk of heart disease, new research suggests.
Chronic inflammation in people with psoriasis is associated with the development of plaque in heart arteries, which increases the risk of coronary artery disease. In biologic therapy, patients receive protein-based infusions to reduce inflammation.
A simple blood test may predict which COVID-19 patients are likely to get worse and die, a new study suggests.
"When we first started treating COVID-19 patients, we watched them get better or get worse, but we didn't know why," said researcher Dr. Juan Reyes. He's an assistant professor of medicine at the George Washington School of Medicine and Health Sciences, in Washington, D.C.
There are currently no medications that can slow down the common form of arthritis that strikes aging knees and hips. But a new study suggests a powerful, and expensive, anti-inflammatory drug could potentially do just that.
The drug, called canakinumab (Ilaris), is used for certain rare rheumatic conditions marked by widespread inflammation. They include juvenile idiopathic arthritis...
An infusion of cells that dampen the body's immune response might help people with severe cases of the new coronavirus recover more quickly, a new report suggests.
Two patients so sick with COVID-19 that they'd been put on a ventilator improved quickly when given an infusion of regulatory T-cells, which are cells that check the immune system and prevent it from overreacting to an infe...
There's new evidence that a 2,000-year-old medicine might offer hope against a modern scourge: COVID-19.
The medication, called colchicine, is an anti-inflammatory taken as a pill. It's long been prescribed for gout, a form of arthritis, and its history goes back centuries. The drug was first sourced from the autumn crocus flower.